Inhibitor Therapeutics, Inc. Stock Issued During Period, Value, Stock Dividend
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Inhibitor Therapeutics, Inc. stock issued during period, value, stock dividend for the quarter ending 2020-09-30 was $200.55K.
- Inhibitor Therapeutics, Inc. stock issued during period, value, stock dividend for the quarter ending 2019-03-31 was $99.95K.
- Inhibitor Therapeutics, Inc. stock issued during period, value, stock dividend for the quarter ending 2018-12-31 was -$1.00.
- Inhibitor Therapeutics, Inc. stock issued during period, value, stock dividend for the quarter ending 2018-09-30 was $56.55K.
- Inhibitor Therapeutics, Inc. stock issued during period, value, stock dividend for fiscal 2021 was $200.00K, a 0.27% decline from fiscal 2020.
- Inhibitor Therapeutics, Inc. stock issued during period, value, stock dividend for fiscal 2020 was $200.55K, a 100.66% increase from fiscal 2019.
- Inhibitor Therapeutics, Inc. stock issued during period, value, stock dividend for fiscal 2019 was $99.95K, a 76.75% increase from fiscal 2018.
- Inhibitor Therapeutics, Inc. stock issued during period, value, stock dividend for fiscal 2018 was $56.55K.
| Period end | Stock Issued During Period, Value, Stock Dividend 3 month | Stock Issued During Period, Value, Stock Dividend 12 month |
|---|---|---|
| 2021-12-31 | $200.00K 10-K · filed 2023-03-31 | |
| 2020-12-31 | $200.55K 10-K · filed 2022-03-30 | |
| 2020-09-30 | $200.55K 10-Q · filed 2020-11-16 | |
| 2019-12-31 | $99.95K 10-K · filed 2021-03-26 | |
| 2019-03-31 | $99.95K 10-Q · filed 2020-11-16 | |
| 2018-12-31 | -$1.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $56.55K 10-K · filed 2020-03-30 |
| 2018-09-30 | $56.55K 10-Q · filed 2019-11-07 |